BROOKFIELD Corp /ON/

Q2 2020 13F Combination Report, New Holdings, Stock Holdings

Signature - Title
Ronald Fisher-Dayn - Managing Partner and Chief Compliance Officer
Location
Toronto, Ontario, Canada
Holdings as of
June 30, 2020
Value $
$59.7M
Num holdings
1
Date filed
5/17/2022, 09:46 AM
Description
Request for Confidential Treatment (8/14/2020): Confidential Treatment Expired on 5/16/2022
Previous filing
Q1 2020 - May 15, 2020
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 08-14-2020 pursuant to a request for confidential treatment and for which confidential treatment expired on 05-16-2022.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ronald Fisher-Dayn MANAGING DIRECTOR, LEGAL & REGULATORY NY, New York 5/16/2022

THIS FILING LISTS SECURITIES HOLDINGS REPORTED ON THE FORM 13F FILED ON August 14, 2020 PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FOR WHICH CONFIDENTIAL TREATMENT WILL EXPIRE ON MAY 16, 2022.

List of Other Managers Reporting for BROOKFIELD Corp /ON/:

Name Holdings Value Location File Number
OAKTREE CAPITAL MANAGEMENT LP $5.8B Los Angeles, CA 028-05050
Oaktree Fund Advisors, LLC $107M Los Angles, CA 028-21340

Other Included Managers (1):

Num Name File Number
3 Brookfield Asset Management Private Institutional Capital Adviser US, LLC 028-16270